Samuel Moser;Hans Koll;Klaus-Peter Kuenkele;Sylke Poehling
发明人:
Hans Koll,Klaus-Peter Kuenkele,Samuel Moser,Sylke Poehling
申请号:
US13195955
公开号:
US20120076778A1
申请日:
2011.08.02
申请国别(地区):
US
年份:
2012
代理人:
摘要:
An antibody binding to IGF-IR and being glycosylated with a sugar chain at Asn297, said antibody being characterized in that the amount of fucose within said sugar chain is between 20% and 50%, has improved properties in antitumor therapy.